Global X Management Company’s Integra LifeSciences IART Stock Holding History

Global X Management Company’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$67K	Buy	1,039 +293	+39%	+$18.1K	﹤0.01%	1047
2018 Q1	$41K	Buy	746 +187	+33%	+$9.8K	﹤0.01%	1045
2017 Q4	$27K	Buy	559 +127	+29%	+$6.22K	﹤0.01%	1004
2017 Q3	$22K	Buy	432 +62	+17%	+$3.18K	﹤0.01%	1054
2017 Q2	$20K	Buy	370 +225	+155%	+$10.7K	﹤0.01%	1149
2017 Q1	$6K	Buy	145 +9	+7%	+$385	﹤0.01%	1167
2016 Q4	$6K	Hold	136	–	–	﹤0.01%	1049
2016 Q3	$6K	Hold	136	–	–	﹤0.01%	1048
2016 Q2	$5K	Buy	+136	New	+$4.89K	﹤0.01%	929

Other funds holding IART

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Global X Management Company's IART Position: Q2 2018 in Review

Global X Management Company increased its Integra LifeSciences (IART) stake by 39% in Q2 2018, buying an estimated $18.1K and bringing the position to 1,039 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

Global X Management Company first reported a position in IART in Q2 2016 and has held it in 9 quarters since. 257 funds tracked by Wall St. Rank hold IART as of Q2 2018.

Global X Management Company held 1,039 shares of Integra LifeSciences worth $67K as of Q2 2018.
Global X Management Company bought 293 Integra LifeSciences shares in Q2 2018, an estimated $18.1K.
Integra LifeSciences made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1047 holding.
Global X Management Company first reported a position in Integra LifeSciences in Q2 2016 and has held it in 9 quarters since.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.